Waters Corporation

This week, the Waters teams have been busy with three concurrent events in Boston: the TIDES USA Congress, the Protein & Antibody Engineering Summit (PEGS), and the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, to connect directly with the scientists advancing today’s most complex therapeutics. Talks and posters focused on generating data you can trust when molecules and modalities don’t behave simply or predictably. From oligonucleotides and peptides to monoclonal antibodies and emerging cell and gene therapies, the conversations centered on practical ways to better characterize complexity, improve reproducibility, and scale with confidence. With new tools launching soon, sign up to be the first to know more! GLP-1s: https://bit.ly/3RbRTDQ LNPs: https://bit.ly/4tAjrjF

Join this webinar to explore how salivary cortisone testing using LC-MS/MS can improve the detection and monitoring of conditions like Cushing's syndrome and adrenal insufficiency. Hear real-world insights from clinical practice and learn how advanced methods can support more confident decision-making. Register today! https://bit.ly/4u7yge8

Make your morning at ASMS 2026 count. Join the Waters Breakfast Seminars for exclusive access to expert-led sessions and early insights into the latest advances in mass spectrometry, before the show floor opens. The sessions will give you: • Practical takeaways that you can apply immediately • Perspectives from other leaders in the field • A smarter way to start your conference day Learn, connect, and stay ahead, without sacrificing your schedule. View the agenda and register to start your day right: https://bit.ly/3QStwuU

On the sidelines of the seventy-ninth World Health Assembly, Foreign Policy will convene for the 2026 Global Health Forum, bringing leaders together to explore how financing, innovation, and policy must evolve to build more sustainable, prevention-led health systems. Caitlin Asjes, Head of Global Policy and Access, Waters Advanced Diagnostics, will join John-Arne Røttingen, CEO Wellcome Trust, and Dr. KJ Seung, Senior Advisor, Partners In Health, for a discussion on partnerships for equitable access in global health security. Together, they will focus on how stronger collaboration across governments, NGOs, and industry can turn diagnostics and data into real health system resilience. Register to join us. https://bit.ly/4dpeggz #WHA79

Momentum is building. See you at ASMS. Reserve your seat now: https://bit.ly/4dqqGpu #ASMS2026

Jim Cramer, host of CNBC's Mad Money, speaks with CEO Udit Batra about the strong performance and momentum of our newly combined company, following incredible Q1 2026 financial results. "Now we have the first quarter of the combined company and the numbers are just excellent. That's why the stock shot up 13.5 %, making it the best performer in the S&P 500," said Jim, as he spoke to Udit about the synergies between Waters and the recently acquired BD Biosciences and Diagnostic Solutions businesses. Watch the full interview here: https://bit.ly/4uFVKr7

What happens when native MS isn’t enough? As biomolecular systems grow ever more complex, traditional approaches struggle to deliver accurate mass and structural insight. Join our webinar to discover how charge detection mass spectrometry (CDMS) is redefining mass characterization for complex bioconjugates and viruses - through real‑world case studies from biopharma scientists and experts in structural virology. You’ll hear from: Prof. Charlotte Uetrecht (University of Lübeck, CSSB), who will show how CDMS reveals viral capsid heterogeneity and assembly using norovirus. Dr. Andi Flütsch (Johnson & Johnson Innovative Medicine), who will discuss the characterization of highly heterogeneous glycoprotein vaccines. Learn more and register today at https://bit.ly/4tIAosG

We are honored to be named 2025 Company of the Year by Instrument Business Outlook, a Science and Medicine Group publication. This recognition reflects a year of steady growth, innovation, and operational excellence, including the decision to combine with the BD Biosciences and Diagnostics Solutions businesses. Most importantly, it reflects the focus and dedication of our teams to navigate a complex global environment while serving customers around the world. ➡️ Read the full article to learn more: https://bit.ly/4eTAutk

Join Dr. Sujan Fernando at the Waters ASMS 2026 Users Meeting as he explores the impact of PFAS contamination in the Great Lakes of North America, revealing how mass spectrometry is being used to evaluate temporal trends and provide comparisons with historical data. Reserve your seat now: https://bit.ly/4uBGf3I

See you at ASMS. Reserve your seat now: https://bit.ly/4dqqGpu #ASMS2026